Synutra sees 3Q sales rise 14%
date:Feb 13, 2014
s, we continue to upgrade our production standards to comply with evolving regulations. Over the long term, our French drying facility will provide a sustainable, secure supply of high-quality raw materials. Second, as the only licensed domestic producer of medical-purpose specialty formula, we are uniquely positioned to capitalize on marketing and sales in the medical channel. This advantage has helped us regain our growth momentum. Third, in light of the Chinese government's support of industr
4/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/04 13:46